Down 39% in a year.
₹198.23
NSE close · 17 Sep
+14.77%6M
20-day support and resistance
Down 39% in a year.
NSE close · 17 Sep
Loading quarterly results.
Loading financial history.
+0.3% vs price
-4.6% vs price
-8.0% vs price
Bulk deal22 May
₹8.53 cr
Nothing filed yet.
1Public Shareholders
58.20%
2Promoter and Promoter Group
41.80%
3Orbimed Asia Ii Mauritius Ltd
22.41%
4Rajesh Vrajlal Khakhar
16.95%
5Sameer Kamlesh Merchant
15.83%
Shares +0.2% since 31 Mar
6Jigna Rajesh Khakhar
7.84%
7Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
4.68%
Shares -6.2% since 31 Mar
8Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
3.50%
9Amrish Desai
2.02%
10Parag Jamnadas Bhimjiyani
2.02%
11Hdfc Mutual Fund - Hdfc Pharma And Healthcare Fund
1.37%
12Eastspring Investments - Asia Growth Opportunities Equity Fund
1.23%
Shares -41.4% since 31 Mar